These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 18712173)
1. Expression of extracellular matrix metalloproteinase (MMP-9), E-cadherin and proliferation-associated antigen Ki-67 and their reciprocal correlation in canine mammary adenocarcinomas. Nowak M; Madej JA; Podhorska-Okolow M; Dziegiel P In Vivo; 2008; 22(4):463-9. PubMed ID: 18712173 [TBL] [Abstract][Full Text] [Related]
2. Expression of E-cadherin, beta-catenin and Ki-67 antigen and their reciprocal correlations in fibrosarcomas of soft tissues in dogs. Nowak M; Madej JA; Dziegiel P In Vivo; 2007; 21(5):751-6. PubMed ID: 18019408 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical identification method of tumour cells in the S phase of mitotic cycle and its usefulness in diagnostics of mammary gland adenocarcinomas in bitches. Nowak M; Madej JA; Dziegiel P; Kanzawa H Pol J Vet Sci; 2006; 9(1):57-62. PubMed ID: 16573276 [TBL] [Abstract][Full Text] [Related]
4. Expression of E-cadherin, beta-catenin and Ki-67 antigen and their reciprocal relationships in mammary adenocarcinomas in bitches. Nowak M; Madej JA; Dziegiel P Folia Histochem Cytobiol; 2007; 45(3):233-8. PubMed ID: 17951173 [TBL] [Abstract][Full Text] [Related]
5. Correlation between MCM-3 protein expression and grade of malignancy in mammary adenocarcinomas and soft tissue fibrosarcomas in dogs. Nowak M; Madej JA; Dziegiel P In Vivo; 2009; 23(1):49-53. PubMed ID: 19368124 [TBL] [Abstract][Full Text] [Related]
6. Expression of beta-catenin, E-cadherin and APC in canine mammary tumors. Restucci B; Maiolino P; Martano M; Esposito G; De Filippis D; Borzacchiello G; Lo Muzio L Anticancer Res; 2007; 27(5A):3083-9. PubMed ID: 17970048 [TBL] [Abstract][Full Text] [Related]
7. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression. Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904 [TBL] [Abstract][Full Text] [Related]
8. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival. Gama A; Paredes J; Gärtner F; Alves A; Schmitt F Vet J; 2008 Jul; 177(1):45-53. PubMed ID: 17631398 [TBL] [Abstract][Full Text] [Related]
9. E-cadherin expression in canine malignant mammary tumours: relationship to other clinico-pathological variables. Matos AJ; Lopes C; Carvalheira J; Santos M; Rutteman GR; Gärtner F J Comp Pathol; 2006; 134(2-3):182-9. PubMed ID: 16545841 [TBL] [Abstract][Full Text] [Related]
10. Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma. Kuniyasu H; Ellis LM; Evans DB; Abbruzzese JL; Fenoglio CJ; Bucana CD; Cleary KR; Tahara E; Fidler IJ Clin Cancer Res; 1999 Jan; 5(1):25-33. PubMed ID: 9918199 [TBL] [Abstract][Full Text] [Related]
11. E-cadherin and beta-catenin reduction influence invasion but not proliferation and survival in canine malignant mammary tumors. Brunetti B; Sarli G; Preziosi R; Monari I; Benazzi C Vet Pathol; 2005 Nov; 42(6):781-7. PubMed ID: 16301574 [TBL] [Abstract][Full Text] [Related]
12. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53. Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357 [TBL] [Abstract][Full Text] [Related]
13. [Peculiarities of E-cadherin, mucin-2, and Ki-67 expression in colon adenocarcinoma]. Korsakova NA Arkh Patol; 2003; 65(5):15-8. PubMed ID: 14664141 [TBL] [Abstract][Full Text] [Related]
14. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours. Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573 [TBL] [Abstract][Full Text] [Related]
15. MIB-1 labelling indices according to clinico-pathological variables in canine mammary tumours: a multivariate study. De Matos AJ; Lopes CC; Faustino AM; Carvalheira JG; Dos Santos MS; Rutteman GR; Gärtner Mde F Anticancer Res; 2006; 26(3A):1821-6. PubMed ID: 16827113 [TBL] [Abstract][Full Text] [Related]
16. E-cadherin immunohistochemical expression in mammary gland neoplasms in bitches. Rodo A; Malicka E Pol J Vet Sci; 2008; 11(1):47-54. PubMed ID: 18540208 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: a survival study. Santos A; Lopes C; Frias C; Amorim I; Vicente C; Gärtner F; Matos Ad Vet J; 2011 Dec; 190(3):396-402. PubMed ID: 21269852 [TBL] [Abstract][Full Text] [Related]
18. Expression of peroxisome proliferator-activated receptor gamma, E-cadherin and matrix metalloproteinases-2 in gastric carcinoma and lymph node metastases. He Q; Chen J; Lin HL; Hu PJ; Chen MH Chin Med J (Engl); 2007 Sep; 120(17):1498-504. PubMed ID: 17908458 [TBL] [Abstract][Full Text] [Related]
19. Increased Derlin-1 expression in metastases of canine mammary adenocarcinomas. Klopfleisch R; Schütze M; Linzmann H; Brunnberg L; Gruber AD J Comp Pathol; 2010 Jan; 142(1):79-83. PubMed ID: 19632687 [TBL] [Abstract][Full Text] [Related]